日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors

利用细胞周期蛋白A/B RxL抑制剂靶向G1-S检查点受损的癌症

Shilpa Singh ,Catherine E Gleason ,Min Fang ,Yasmin N Laimon ,Vishal Khivansara ,Shanhai Xie ,Yavuz T Durmaz ,Aniruddha Sarkar ,Kenneth Ngo ,Varunika Savla ,Yixiang Li ,Muhannad Abu-Remaileh ,Xinyue Li ,Marie-Anais Locquet ,Bishma Tuladhar ,Ranya Odeh ,Frances Hamkins-Indik ,Daphne He ,Miles W Membreno ,Meisam Nosrati ,Nathan N Gushwa ,Siegfried S F Leung ,Breena Fraga-Walton ,Luis Hernandez ,Miguel P Baldomero ,Bryan M Lent ,David Spellmeyer ,Joshua F Luna ,Dalena Hoang ,Yuliana Gritsenko ,Manesh Chand ,Megan K DeMart ,Sammy Metobo ,Chinmay Bhatt ,Justin A Shapiro ,Kai Yang ,Nathan J Dupper ,Andrew T Bockus ,Jinshu Fang ,Ramesh Bambal ,Peadar Cremin ,John G Doench ,James B Aggen ,Li-Fen Liu ,Bernard Levin ,Evelyn W Wang ,Iolanda Vendrell ,Roman Fischer ,Benedikt Kessler ,Prafulla C Gokhale ,Sabina Signoretti ,Alexander Spektor ,Constantine Kreatsoulas ,Marie Evangelista ,Rajinder Singh ,David J Earp ,Deepak Nijhawan ,Pablo D Garcia ,Matthew G Oser

Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy

利用CAR-T细胞疗法靶向TROP2,根除EGFR突变型非小细胞肺癌中的耐药性持续细胞

Simon Baldacci ,Elliott J Brea ,Francesco Facchinetti ,Zhaorong Li ,Kenneth Ngo ,Soumya Malhotra ,Matthew A Booker ,Michael Yevgeniy Tolstorukov ,Sachiv Chakravarti ,Conor Hinchey ,Navin R Mahadevan ,Filippo Lococo ,Simona D'Agnelli ,Letizia Gnetti ,Nicoletta Campanini ,Alessandro Leonetti ,William W Feng ,Jeanelle A Tsai ,Antja-Voy Hartley ,Marie-Anaïs Locquet ,Ludovic Fournel ,Marco Alifano ,Audrey Mansuet-Lupo ,Aisha Saldanha ,William Haller ,Lauren M Zasadil ,Magdalena Zielinska ,Karen Bui ,Bishma Tuladhar ,Patrick Hall Lizotte ,Elena V Ivanova ,Lecia V Sequist ,Prafulla C Gokhale ,Cloud P Paweletz ,Eric L Smith ,Pasi A Jänne ,David A Barbie

Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors

系统性改造TROP2靶向CAR T细胞疗法可克服实体瘤的耐药通路

Elliott J Brea,Simon Baldacci,Neil Savage,Francesco Facchinetti,Conor Hinchey,Sachiv Chakravarti,Alexis Mottram,Kenneth Ngo,Ha Vo,Brittaney A Leeper,Bishma Tuladhar,Suthakar Ganapathy,Elena V Ivanova,Aisha Saldanha,Marie-Anais Locquet,Abdulmajeed Salamah,Malcolm Holterhus,Evelyn B Mesler,Martina De Vizio,Carla Stornante,Marco Campisi,Navin R Mahadevan,Tran C Thai,Timothy J Haggerty,Zehua Li,Cui Nie,Changjing Deng,Xiaoxiao Wang,Louis L Liu,Thanh U Barbie,Prafulla C Gokhale,Cloud P Paweletz,Anusuya Ramasubramanian,Pasi A Jänne,David A Barbie,Eric L Smith

Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review

癌症及治疗特异性免疫检查点抑制剂诱发免疫相关不良事件的发生率:系统评价

Jayathilaka, Bishma; Mian, Farah; Franchini, Fanny; Au-Yeung, George; IJzerman, Maarten

Virotherapy as Gene Deliver for Anti-Cancer Therapy: A Review Article

病毒疗法作为抗癌治疗的基因递送方式:一篇综述文章

Zalfa, Fakhren Nukha; Suciani, Nurul Hikma; Dewi, Putu Ananda Arviana; Khusna, Anissafa Atul; Nurlita, Rima; Daniswara, Dion Bishma; Putri, Anisa Oktaviana; Artasasta, Muh Ade